Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor Stimulation
Open Access
- 1 November 2017
- journal article
- pain medicine
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 127 (5) , 878-889
Abstract
Background: Prolonged opioid administration leads to tolerance characterized by reduced analgesic potency. Pain management is additionally compromised by the hedonic effects of opioids, the cause of their misuse. The multifunctional protein β-arrestin2 regulates the hedonic effects of morphine and participates in tolerance. These actions might reflect µ opioid receptor up-regulation through reduced endocytosis. β-Arrestin2 also recruits kinases to µ receptors. We explored the role of Src kinase in morphine analgesic tolerance, locomotor stimulation, and reinforcement in C57BL/6 mice.Methods: Analgesic (tail withdrawal latency; percentage of maximum possible effect, n = 8 to 16), locomotor (distance traveled, n = 7 to 8), and reinforcing (conditioned place preference, n = 7 to 8) effects of morphine were compared in wild-type, µ+/–, µ–/–, and β-arrestin2–/–mice. The influence of c-Src inhibitors dasatinib (n = 8) and PP2 (n = 12) was examined.Results: Analgesia in morphine-treated wild-type mice exhibited tolerance, declining by day 10 to a median of 62% maximum possible effect (interquartile range, 29 to 92%). Tolerance was absent from mice receiving dasatinib. Tolerance was enhanced in µ+/–mice (34% maximum possible effect; interquartile range, 5 to 52% on day 5); dasatinib attenuated tolerance (100% maximum possible effect; interquartile range, 68 to 100%), as did PP2 (91% maximum possible effect; interquartile range, 78 to 100%). By contrast, c-Src inhibition affected neither morphine-evoked locomotor stimulation nor reinforcement. Remarkably, dasatinib not only attenuated tolerance but also reversed established tolerance in µ+/–mice.Conclusions: The ability of c-Src inhibitors to inhibit tolerance, thereby restoring analgesia, without altering the hedonic effect of morphine, makes c-Src inhibitors promising candidates as adjuncts to opioid analgesics.Keywords
This publication has 45 references indexed in Scilit:
- Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacologyDrug and Alcohol Dependence, 2012
- Blockade of PDGFR-β activation eliminates morphine analgesic toleranceNature Medicine, 2012
- Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and TolerancePharmacological Reviews, 2011
- The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal CancerJNCI: Journal of the National Cancer Institute, 2011
- Analgesic Tone Conferred by Constitutively Active Mu Opioid Receptors in Mice Lacking β-Arrestin 2Molecular Pain, 2011
- A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in MiceNeuropsychopharmacology, 2010
- Src Phosphorylation of μ-Receptor Is Responsible for the Receptor Switching from an Inhibitory to a Stimulatory SignalJournal of Biological Chemistry, 2009
- Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complexNature Medicine, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Alternative splicing controls G protein–dependent inhibition of N-type calcium channels in nociceptorsNature Neuroscience, 2007